LifeAssays® collaboration partner Abreos and the FDA in collaboration to develop method for measuring the concentration of active drug in blood.
Abreeos has previously announced (see link https://medtechinnovator.org/abreos-biosciences-announces-research-collaboration-with-fda-cder/) a research collaboration with the FDA to measure blood drug concentrations based on Veritope ™ technology. The Veritope™ technology is the basis of the collaboration in Aegirbio and the Company will commercialize.The FDA's "Center for Drug Evaluation and Research (CDER)" has initiated a research collaboration with Abreos Biosciences to develop methods to measure biological drug concentrations in blood with high sensitivity and specificity. Abreo's